Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): Their affinities for cannabinoid receptors and pathways of inactivation

Molecular Pharmacology

Volumn 54, Issue 1, 1998, Pages 180-188

  Edgemond, William S ^a   Hillard, Cecilia J ^a   Falck, J R ^b   Kearn, Christopher S ^a   Campbell, William B ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ANANDAMIDE; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; LIPOXYGENASE; OXYGEN;

ANIMAL TISSUE; ARTICLE; CELL METABOLISM; CHROMATOGRAPHY; HALF LIFE TIME; HUMAN; HUMAN CELL; LIGAND BINDING; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION; THROMBOCYTE;

EID: 0031820286     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.54.1.180     Document Type: Article

References (39)

1. Baldwin JE, Davies DI, Hughes L, and Gutteridge NJA (1979) Synthesis from arachidonic acid of potential prostaglandin precursors. J Chem Soc Perkins Trans I 115-121.
2. Bayewitch M, Avidor-Reiss T, Levy R, Barg J, Mechoulam R, and Vogel Z (1995) The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling. FEBS Lett 375:143-147.
3. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-252.
4. Borgeat P and Samuelsson B (1979) Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187. Proc Natl Acad Sci USA 76:2148-2152.
5. Boyum A (1968) Isolation of mononuclear cells and granulocytes from human blood: isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. J Clin Lab Invest 21:77-98.
6. Calignano A, La Rana G, Beltramo M, Makriyannis A, and Piomelli D (1997) Potentiation of anandamide hypotension by the transport inhibitor, AM404. Eur J Pharmacol 337: R1-R2.
7. Callahan KS, Johnson AR, and Campbell WB (1985) Enhancement of the antiaggregatory activity of prostacyclin by propanolol in human platelets. Circulation 71:1237-1246.
8. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3110.
9. Das SK, Paria BC, Chakraborty I, and Dey SK (1995) Cannabinoid ligand-receptor signaling in the mouse uterus. Proc Natl Acad Sci USA 92:4332-4336.
10. Deutsch DG and Chin SA (1993) Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem Pharmacol 47:711-715.
11. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, and Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science (Washington DC) 258:1946-1949.
12. Facci L, Dal Toso R, Romanello S, Buriani A, Skaper SD, and Leon A (1995) Mast cells express a peripheral Cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci USA 92:3376-3380.
13. Felder CC, Joyce KE, Briley EM, Mansouri J, Mackie K, Blond O, Lai Y, Ma AL, and Mitchell RL (1995) Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol Pharmacol 48:443-450.
14. Fretland DJ and Djuric SW (1989) 12(R) And 12(S)-hydroxyeicosatetraenoic acids stimulate the human polymorphonuclear leukocytes. Prostag Leuko Ess Fatty Acids 38:215-228.
15. Fride E and Mechoulam R (1993) Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur J Pharmacol 231:313-314.
16. Galiegue S, Mary S, Marchand J, Dussossoy D, Carriere D, Carayon P, Bouaboula M, Shire D, Le Fur G, and Casellas P (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 232:54-61.
17. Hampson AJ, Hill WAG, Zan-Phillips M, Makriyannis A, Leung E, Eglen RM, and Bornheim LM (1995) Anandamide hydroxylation by brain lipoxygenase: metabolite structures and potencies at the cannabinoid receptor. Biochim Biophys Acta 1259:173-179.
18. Hillard CJ, Edgemond WS, and Campbell WB (1995) Characterization of ligand binding to the cannabinoid receptor of rat brain membranes using a novel method: application to anandamide. J Neurochem 64:677-683.
19. Hillard CJ, Edgemond WS, Jarrahian A, and Campbell WB (1997) Accumulation of N-arachidonylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion. J Neurochem 69:631-638.
20. Jung G, Yang DC, and Nakao A (1985) Oxygenation of phosphatidylcholine by human polymorphonuclear leukocyte 15-lipoxygenase. Biochem Biophys Res Commun 130:559-566.
21. Mackie K, Devane WA, and Hille B (1993) Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. Mol Pharmacol 44:498-503.
22. Manna S, Falck JR, Chacos N, and Capdevila J (1983) Synthesis of arachidonic acid metabolites produced by purified kidney cortex microsomal cytochrome P-450. Tetrahedron Lett 24:33-36.
23. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, and Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature (Lond) 346:561-564.
24. Munro S, Thomas KL, and Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature (Lond) 365:61-65.
25. Pfister SL, Schmitz JM, Willerson JT, and Campbell WB (1988) Characterization of arachidonic acid metabolism in Watanabe heritable hyperlipidemic (WHHL) and New Zealand White (NZW) rabbit aortas. Prostaglandins 36:515-531.
26. Priller J, Briley EM, Mansouri J, Devane WA, Mackie K, and Felder CC (1995) Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors. Mol Pharmacol 48:288-292.
27. Rosolowsky M, Falck JR, and Campbell WB (1996) Metabolism of arachidonic acid by canine polymorphonuclear leukocytes: synthesis of lipoxygenase and omegaoxidized metabolites. Biochim Biophys Acta 1300:143-150.
28. Ryan WJ, Banner WK, Wiley JL, Martin BR, and Razdan RK (1997) Potent anandamide analogs: the effect of changing the length and branching of the end pentyl chain. J Med Chem 40:3617-3625.
29. Seltzman HH, Fleming DN, Thomas BF, Gilliam AF, McCallion DS, Pertwee RG, Compton DR, and Martin BR (1997) Synthesis and pharmacological comparison of dimethylheptyl and pentyl analogs of anandamide. J Med Chem 40:3626-3634.
30. Shin DS, Yadagiri P, and Falck JR (1989) Synthesis and structure confirmation of compound D, a proinflammatory arachidonate metabolite. Tetrahedron Lett 30:3923-3926.
31. Smith PB, Compton DR, Welch SP, Razdan RK, Mechoulam R, and Martin BR (1994) The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J Pharmacol Exp Ther 270:219-227.
32. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, and Waku K (1995) 2-Arachidonylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215:89-92.
33. Ueda N, Yamamoto K, Yamamoto S, Tokunaga T, Shirakawa E, Shinkai H, Ogawa M, Sato T, Kudo I, Inoue K, Takizawa H, Nagano T, Hirobe M, Matsuki N, and Saito H (1995) Lipoxygenase-catalyzed oxygenation of arachidonylethanolamide, a cannabinoid receptor agonist. Biochim Biophys Acta 1254:127-134.
34. Van der Stelt M, Paoletti AM, Maccarrone M, Nieuwenhuizen WF, Bagetta G, Veldink GA, Agro AF, and Vliegenthart JF. The effect of hydroxylation of linoleoyl amides on their cannabinomimetic properties. FEBS Lett 415:313-316 (1997).
35. Vogel Z, Barg J, Levy R, Saya D, Heldman E, and Mechoulam R (1993) Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. J Neurochem 61:352-355.
36. Willoughby KA, Moore SF, Martin BR, and Ellis EF (1997) The biodisposition and metabolism of anandamide in mice. J Pharmacol Exp Ther 282:243-247.
37. Wise ML, Soderstrom K, Murray TF, and Gerwick WH (1996) Synthesis and cannabinoid receptor binding activity of conjugated triene anandamide, a novel eicosanoid. Experientia 52:88-92.
38. Yadagiri P, Lumin S, Mosset P, Capdevila J, and Falck JR (1986) Enantiospecific total synthesis of 8- and 12-hydroxyeicosatetraenoic acid. Tetrahedron Lett 27:6039-6040.
39. Yamamoto S (1992) Mammalian lipoxygenases: molecular structures and functions. Biochim Biophys Acta 1128:117-131.